Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-24
DOI
10.3389/fncel.2020.00170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CDK5: A Unique CDK and Its Multiple Roles in the Nervous System
- (2019) Nicole Cortés et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer’s Disease
- (2019) Susan A. Farr et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin Promotes Anxiolytic and Antidepressant-Like Responses in Insulin-Resistant Mice by Decreasing Circulating Branched-Chain Amino Acids
- (2019) Juliane Zemdegs et al. JOURNAL OF NEUROSCIENCE
- Metformin and risk of Alzheimer’s disease among community-dwelling people with diabetes: a national case-control study
- (2019) Janet K Sluggett et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
- (2018) Zhenri Ou et al. BRAIN BEHAVIOR AND IMMUNITY
- Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson’s Disease Mouse Model
- (2018) Rongni He et al. Frontiers in Aging Neuroscience
- The Therapeutic Potential of Metformin in Neurodegenerative Diseases
- (2018) Carola Rotermund et al. Frontiers in Endocrinology
- Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases
- (2018) Andre F. Batista et al. CNS DRUGS
- The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review)
- (2017) Jing Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice
- (2017) Varsha Shukla et al. JOURNAL OF ALZHEIMERS DISEASE
- Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
- (2017) Jinsoo Seo et al. JOURNAL OF NEUROSCIENCE
- Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
- (2017) Yang Bai et al. Molecular Neurodegeneration
- Metformin ameliorates core deficits in a mouse model of fragile X syndrome
- (2017) Ilse Gantois et al. NATURE MEDICINE
- Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model
- (2016) R E Monyak et al. MOLECULAR PSYCHIATRY
- Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
- (2016) Verena Leidgens et al. Oncotarget
- Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology
- (2015) Yanghui Sheng et al. CEREBRAL CORTEX
- The Role of Cdk5 in Alzheimer’s Disease
- (2015) Shu-Lei Liu et al. MOLECULAR NEUROBIOLOGY
- S-nitrosylation-dependent proteasomal degradation restrains Cdk5 activity to regulate hippocampal synaptic strength
- (2015) Peng Zhang et al. Nature Communications
- Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
- (2015) Jinan Chen et al. PLoS One
- Type 3 diabetes is sporadic Alzheimer׳s disease: Mini-review
- (2014) Suzanne M. de la Monte EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Memory Enhancement by Targeting Cdk5 Regulation of NR2B
- (2014) Florian Plattner et al. NEURON
- Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer’s disease
- (2014) Amy K. Y. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
- (2013) Christian Hölscher JOURNAL OF ENDOCRINOLOGY
- Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons
- (2013) Du-Hyong Cho et al. JOURNAL OF NEUROCHEMISTRY
- Specific Inhibition of p25/Cdk5 Activity by the Cdk5 Inhibitory Peptide Reduces Neurodegeneration In Vivo
- (2013) J. R. Sundaram et al. JOURNAL OF NEUROSCIENCE
- Recent developments of protein kinase inhibitors as potential AD therapeutics
- (2013) Volkmar Tell et al. Frontiers in Cellular Neuroscience
- Deregulated Cdk5 Activity Is Involved in Inducing Alzheimer’s Disease
- (2012) Varsha Shukla et al. ARCHIVES OF MEDICAL RESEARCH
- Cyclin-Dependent Kinases in Brain Development and Disease
- (2011) Susan C. Su et al. Annual Review of Cell and Developmental Biology
- S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by -amyloid peptide
- (2011) J. Qu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cdk5: a multifaceted kinase in neurodegenerative diseases
- (2011) Zelda H. Cheung et al. TRENDS IN CELL BIOLOGY
- Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
- (2010) Kawser Akter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice
- (2010) D. Piedrahita et al. JOURNAL OF NEUROSCIENCE
- S-Nitrosylation of Cyclin-Dependent Kinase 5 (Cdk5) Regulates Its Kinase Activity and Dendrite Growth During Neuronal Development
- (2010) P. Zhang et al. JOURNAL OF NEUROSCIENCE
- How safe is the use of thiazolidinediones in clinical practice?
- (2009) CV Rizos et al. Expert Opinion On Drug Safety
- The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes
- (2009) V. Lalioti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cdk5 Regulates the Phosphorylation of Tyrosine 1472 NR2B and the Surface Expression of NMDA Receptors
- (2008) S. Zhang et al. JOURNAL OF NEUROSCIENCE
- WAVE1 controls neuronal activity-induced mitochondrial distribution in dendritic spines
- (2008) J. Y. Sung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search